Fujian Aonong Biological Technology Group Incorporation Limited (603363.SS)
CNY 3.69
(-1.07%)
CNY 3.69
(-1.07%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 13.95 Billion CNY | -8.35% |
| 2022 | 15.22 Billion CNY | 2.15% |
| 2021 | 14.9 Billion CNY | 83.69% |
| 2020 | 8.11 Billion CNY | 123.07% |
| 2019 | 3.63 Billion CNY | 58.45% |
| 2018 | 2.29 Billion CNY | 46.01% |
| 2017 | 1.57 Billion CNY | 40.66% |
| 2016 | 1.11 Billion CNY | 23.83% |
| 2015 | 902.84 Million CNY | 26.82% |
| 2014 | 711.92 Million CNY | 17.85% |
| 2013 | 604.09 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 13.55 Billion CNY | 0.65% |
| 2024 Q1 | 13.46 Billion CNY | -3.55% |
| 2024 Q3 | 13.26 Billion CNY | -2.12% |
| 2023 Q4 | 13.95 Billion CNY | -5.63% |
| 2023 Q2 | 14.86 Billion CNY | -3.63% |
| 2023 Q1 | 15.42 Billion CNY | 1.28% |
| 2023 FY | 13.95 Billion CNY | -8.35% |
| 2023 Q3 | 14.78 Billion CNY | -0.49% |
| 2022 Q1 | 15.99 Billion CNY | 7.27% |
| 2022 FY | 15.22 Billion CNY | 2.15% |
| 2022 Q4 | 15.22 Billion CNY | 2.51% |
| 2022 Q2 | 15.45 Billion CNY | -3.37% |
| 2022 Q3 | 14.85 Billion CNY | -3.86% |
| 2021 Q2 | 12.66 Billion CNY | 12.44% |
| 2021 Q3 | 13.76 Billion CNY | 8.68% |
| 2021 Q4 | 14.9 Billion CNY | 8.27% |
| 2021 FY | 14.9 Billion CNY | 83.69% |
| 2021 Q1 | 11.26 Billion CNY | 38.84% |
| 2020 Q2 | 4.54 Billion CNY | 7.39% |
| 2020 Q4 | 8.11 Billion CNY | 18.98% |
| 2020 Q3 | 6.82 Billion CNY | 50.02% |
| 2020 FY | 8.11 Billion CNY | 123.07% |
| 2020 Q1 | 4.23 Billion CNY | 16.38% |
| 2019 Q4 | 3.63 Billion CNY | 11.5% |
| 2019 FY | 3.63 Billion CNY | 58.45% |
| 2019 Q2 | 2.83 Billion CNY | 14.09% |
| 2019 Q3 | 3.26 Billion CNY | 15.03% |
| 2019 Q1 | 2.48 Billion CNY | 8.29% |
| 2018 Q2 | 2.15 Billion CNY | 5.93% |
| 2018 FY | 2.29 Billion CNY | 46.01% |
| 2018 Q4 | 2.29 Billion CNY | -0.76% |
| 2018 Q3 | 2.31 Billion CNY | 7.22% |
| 2018 Q1 | 2.03 Billion CNY | 29.54% |
| 2017 FY | 1.57 Billion CNY | 40.66% |
| 2017 Q1 | - CNY | -100.0% |
| 2017 Q2 | 1.32 Billion CNY | 0.0% |
| 2017 Q3 | 1.45 Billion CNY | 9.94% |
| 2017 Q4 | 1.57 Billion CNY | 8.14% |
| 2016 Q4 | 1.11 Billion CNY | 0.0% |
| 2016 FY | 1.11 Billion CNY | 23.83% |
| 2015 FY | 902.84 Million CNY | 26.82% |
| 2014 FY | 711.92 Million CNY | 17.85% |
| 2013 FY | 604.09 Million CNY | 0.0% |